GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tong Ren Tang Technologies Co Ltd (HKSE:01666) » Definitions » Days Sales Outstanding

Tong Ren Tang Technologies Co (HKSE:01666) Days Sales Outstanding : 58.70 (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Tong Ren Tang Technologies Co Days Sales Outstanding?

Tong Ren Tang Technologies Co's average Accounts Receivable for the six months ended in Dec. 2023 was HK$995 Mil. Tong Ren Tang Technologies Co's Revenue for the six months ended in Dec. 2023 was HK$3,092 Mil. Hence, Tong Ren Tang Technologies Co's Days Sales Outstanding for the six months ended in Dec. 2023 was 58.70.

The historical rank and industry rank for Tong Ren Tang Technologies Co's Days Sales Outstanding or its related term are showing as below:

HKSE:01666' s Days Sales Outstanding Range Over the Past 10 Years
Min: 22.13   Med: 41.76   Max: 67.8
Current: 52.67

During the past 13 years, Tong Ren Tang Technologies Co's highest Days Sales Outstanding was 67.80. The lowest was 22.13. And the median was 41.76.

HKSE:01666's Days Sales Outstanding is ranked better than
68.67% of 996 companies
in the Drug Manufacturers industry
Industry Median: 72.035 vs HKSE:01666: 52.67

Tong Ren Tang Technologies Co's Days Sales Outstanding declined from Dec. 2022 (71.14) to Dec. 2023 (58.70).


Tong Ren Tang Technologies Co Days Sales Outstanding Historical Data

The historical data trend for Tong Ren Tang Technologies Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tong Ren Tang Technologies Co Days Sales Outstanding Chart

Tong Ren Tang Technologies Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 53.81 67.80 56.51 59.47 49.44

Tong Ren Tang Technologies Co Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 64.73 60.33 71.14 51.12 58.70

Competitive Comparison of Tong Ren Tang Technologies Co's Days Sales Outstanding

For the Drug Manufacturers - General subindustry, Tong Ren Tang Technologies Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tong Ren Tang Technologies Co's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tong Ren Tang Technologies Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Tong Ren Tang Technologies Co's Days Sales Outstanding falls into.



Tong Ren Tang Technologies Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Tong Ren Tang Technologies Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (1218.102 + 788.866) / 2 ) / 7408.671*365
=1003.484 / 7408.671*365
=49.44

Tong Ren Tang Technologies Co's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (1200.203 + 788.866) / 2 ) / 3092.165*365 / 2
=994.5345 / 3092.165*365 / 2
=58.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tong Ren Tang Technologies Co  (HKSE:01666) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Tong Ren Tang Technologies Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Tong Ren Tang Technologies Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Tong Ren Tang Technologies Co (HKSE:01666) Business Description

Traded in Other Exchanges
Address
No. 16 Tongji Beilu, Beijing Economic and Technological Development Zone, Beijing, CHN
Tong Ren Tang Technologies Co Ltd is engaged in the production and distribution of Chinese medicine and primarily operates in Mainland China and Hong Kong. The operating segments derive their revenue primarily from the manufacture and sale of Chinese medicine of the company in Mainland China and Tong Ren Tang Chinese Medicine and its subsidiaries engaged in manufacturing, retail, and wholesale of Chinese medicine products and healthcare products, and provision of Chinese medical consultation and treatments outside Mainland China and wholesale of healthcare products in Mainland China.
Executives
Citigroup Inc. 2502 Approved lending agent
Hillhouse Capital Advisors, Ltd. 2102 Investment manager
Aberdeen Asset Management Plc And Its Associates 2102 Investment manager

Tong Ren Tang Technologies Co (HKSE:01666) Headlines

No Headlines